生物谷
(920266)
| 流通市值：8.53亿 | | | 总市值：8.93亿 |
| 流通股本：1.18亿 | | | 总股本：1.24亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 200,815,170.91 | 94,694,477.82 | 432,995,308.51 | 304,011,258.04 |
| 营业收入 | 200,815,170.91 | 94,694,477.82 | 432,995,308.51 | 304,011,258.04 |
| 二、营业总成本 | 210,053,857.52 | 99,824,794.56 | 475,523,555.5 | 340,773,972.13 |
| 营业成本 | 73,067,483.12 | 33,888,828.99 | 168,356,437.17 | 122,693,097.38 |
| 税金及附加 | 4,379,515.85 | 2,173,813.46 | 8,472,871.69 | 6,039,296.88 |
| 销售费用 | 88,927,737.98 | 42,768,847.02 | 213,939,815.88 | 145,044,231.18 |
| 管理费用 | 41,155,751.54 | 19,702,588.8 | 77,300,437.98 | 57,297,613.01 |
| 研发费用 | 2,098,803.29 | 1,022,585.8 | 5,589,342.71 | 8,531,145.84 |
| 财务费用 | 424,565.74 | 268,130.49 | 1,864,650.07 | 1,168,587.84 |
| 其中:利息费用 | 446,799.54 | 286,260.71 | 2,350,095.49 | 1,641,776.96 |
| 其中:利息收入 | 30,510.89 | 23,318.19 | 504,719.32 | 488,646.7 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 200,237.08 | - | -1,822,009.61 | - |
| 加:投资收益 | 84,478.72 | -37,137.53 | 309,477.42 | 919,348.05 |
| 资产处置收益 | - | - | 935,245.92 | 886,020.43 |
| 资产减值损失(新) | -298,078.6 | -215,928.28 | -73,545.34 | 287,858.47 |
| 信用减值损失(新) | -1,837,089.79 | -343,242.65 | -4,019,239.15 | -2,424,215.71 |
| 其他收益 | 5,891,946.06 | 1,002,462.71 | 4,666,679.94 | 3,474,742.01 |
| 四、营业利润 | -5,197,193.14 | -4,724,162.49 | -42,531,637.81 | -33,618,960.84 |
| 加:营业外收入 | 1.1 | 81.71 | 61.76 | 335.44 |
| 减:营业外支出 | 97,106.3 | 131.45 | 5,682,501.75 | 293,236.16 |
| 五、利润总额 | -5,294,298.34 | -4,724,212.23 | -48,214,077.8 | -33,911,861.56 |
| 减:所得税费用 | -878,670.91 | -29,027.24 | 3,363,687.63 | 1,596,805.65 |
| 六、净利润 | -4,415,627.43 | -4,695,184.99 | -51,577,765.43 | -35,508,667.21 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -4,415,627.43 | -4,695,184.99 | -51,577,765.43 | -35,508,667.21 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -4,415,627.43 | -4,695,184.99 | -51,577,765.43 | -35,508,667.21 |
| 扣除非经常损益后的净利润 | -9,583,250.59 | -5,515,669.11 | -49,961,935.22 | -39,747,795.51 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.04 | -0.04 | -0.42 | -0.29 |
| (二)稀释每股收益 | -0.04 | - | -0.42 | -0.29 |
| 九、综合收益总额 | -4,415,627.43 | -4,695,184.99 | -51,577,765.43 | -35,508,667.21 |
| 归属于母公司股东的综合收益总额 | -4,415,627.43 | - | -51,577,765.43 | -35,508,667.21 |
| 公告日期 | 2026-08-10 | 2026-04-28 | 2026-04-28 | 2025-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |